The new complexes of Pd(II) with N,N-disubstituted-N 0-acylthioureas:[(1) [Pd(dppf)(N,N-dimethyl-N 0benzoylthioureato-k 2 O,S)]PF 6 , (2) [Pd(dppf)(N,N-diethyl-N 0-benzoylthioureato-k 2 O,S)]PF 6 , (3) [Pd(dppf) (N,N-dibuthyl-N 0-benzoylthioureato-k 2 O,S)]PF 6 , (4) [Pd(dppf)(N,N-diphenyl-N 0-benzoylthioureato-k 2 O, S)]PF 6 , (5) [Pd(dppf)(N,N-diethyl-N 0-furoylthioureato-k 2 O,S)]PF 6 , (6) [Pd(dppf)(N,N-diphenyl-N 0-furoylthioureato-k 2 O,S)]PF 6 , (7) [Pd(dppf)(N,N-dimethyl-N 0-thiophenylthioureato-k 2 O,S)]PF 6 , and (8) [Pd(dppf) (N,N-diphenyl-N 0-thiophenylthioureato-k 2 O,S)]PF 6 , were prepared and characterized by elemental analysis, and spectroscopic techniques. The structures of complexes (2), (3), (5), (6) and (8) had their structures determined by X-ray crystallography, confirming the coordination of the ligands with the metal through sulfur and oxygen atoms, forming distorted square-planar geometries. These complexes have shown antibacterial activity against anti-Mycobacterium tuberculosis H37Rv ATCC 27294. The complexes exhibited antiparasitic activity against Trypanosoma cruzi, while the metal-free thioureas did not. The results demonstrated that the compounds described here can be considered as promising anti-Mycobacterium tuberculosis and anti-T. cruzi agents, since in both cases their in vitro activity were better than reference drugs available for the treatment of both diseases.